Le Lézard
Classified in: Business
Subject: STOCK/OTHER MARKET NEWS

Ayr Strategies Announces Commencement of Trading of Subordinate Voting Shares, Restricted Voting Shares and Limited Voting Shares Under Single Trading Symbol


TORONTO, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Ayr Strategies Inc. (CSE: AYR.A, OTCQX: AYRSF) ("Ayr" or the "Company"), a leading vertically integrated cannabis multi-state operator, is pleased to announce that its amended share structure, overwhelmingly approved at the annual general and special meeting of shareholders held on November 4, 2020, will be reflected in trading effective today. The amendment in share structure was implemented to ensure Ayr's status as a Foreign Private Issuer and reduce compliance costs. Subordinate voting shares (the "Subordinate Voting Shares") and its newly implemented restricted voting shares (the "Restricted Voting Shares") and limited voting shares (the "Limited Voting Shares") will begin trading at the market opening on the Canadian Securities Exchange under the single and current ticker "AYR.A". These shares will bear the CUSIP/ISIN number 00249N209/CA00249N2095 and will be designated for purposes of trading under the single designation of "Subordinate, Restricted and Limited Voting Shares" of Ayr. No action is required by shareholders.

At its annual general and special meeting of shareholders held on November 4, 2020, the shareholders of Ayr approved the amendment and restatement of its articles (the "Amended Articles"), as further described in its management information circular dated September 30, 2020 (the "Circular"), in order to, among other things:

Details of the changes in share structure can be found in the management information circular dated September 30, 2020, available on the Company's website and attached here.

In connection with the Amended Articles, Ayr has applied for, and has received certain exemptive relief (the "Decision") from the Canadian securities administrators to enable its Subordinate Voting Shares, Restricted Voting Shares and Limited Voting Shares to be treated collectively as if they were a single class for certain purposes, including for take-over bid, early warning reporting and normal course issuer bid purposes.

A copy of the Circular, the Amended Articles and the Decision are available on SEDAR at www.sedar.com under Ayr's profile.

About Ayr Strategies Inc.

Ayr Strategies ("Ayr") is an expanding vertically integrated, U.S. multi-state cannabis operator, focusing on high-growth markets. The Company cultivates and manufactures branded cannabis products for distribution through its network of retail outlets and through third-party stores. Ayr strives to enrich consumers' experience every day ? helping them to live their best lives, elevated.

Ayr's leadership team brings proven expertise in growing successful businesses through disciplined operational and financial management, and is committed to driving positive impact for customers, employees and the communities they touch. For more information, please visit www.ayrstrategies.com.

Company Contact:

Megan Kulick, Head of Investor Relations
T: (646) 977-7914
Email: [email protected]

Investor Relations Contact:

Sean Mansouri, CFA or Cody Slach
Gateway Investor Relations
T: (949) 574-3860
Email: [email protected]



These press releases may also interest you

at 16:05
Data I/O Corporation , the leading global provider of advanced security and data deployment solutions for microcontrollers, security ICs and memory devices, today announced financial results for the first quarter ended March 31, 2024. First Quarter...

at 16:05
SkyWest, Inc. ("SkyWest") today reported financial and operating results for Q1 2024, including net income of $60 million, or $1.45 per diluted share, compared to net loss of $22 million, or $0.45 loss per share, for Q1 2023. Commenting on the...

at 16:05
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today...

at 16:05
Stevanato Group S.p.A. , a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the first...

at 16:05
Bruker Corporation today announced it will report first quarter 2024 financial results before market opening on Thursday, May 2, 2024. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current...

at 16:05
Gilead Sciences, Inc. announced today its first quarter 2024 results of operations. "Gilead delivered another strong quarter of revenue growth in the first quarter with 6% year-over-year growth in our base business driven by HIV, Oncology and...



News published on and distributed by: